Staff editor

Innovative Potential of Lonza’s Capsugel® Enprotect® Capsules in Targeted Live Biotherapeutics and Pharmaceutical Applications

Lonza's capsules ensures targeted intestinal delivery enhancing stability and therapeutic efficacy for LBPs and pharmaceutical applications.

Unlocking the hidden world of the small intestine: a new frontier in microbiome science

Cmbio announces a strategic partnership with Nimble Science to deliver first in class high-quality, multi-omic data insights from the small intestine.

Diet, microbiome, and health: decoding the influence of coffee on gut bacteria

Nicola Segata, from University of Trento, investigates the intricate links between diet, microbiome composition, and cardiometabolic outcomes.

The impact of maternal diet and food additives on offspring microbiota and long-term health

Clara Delaroque, from Institut Pasteur (France), emphasizes the critical interplay between early-life microbiota and host health, specifically how the use of common food additives impacts the susceptibility to diseases later…

Cmbio® strengthens its digital biology platform with acquisition of Eagle Genomics’ assets

The acquisition will enhance its ability to address the needs of a growing market, empowering researchers and industries worldwide.

Revolutionizing treatment for Acute Graft-versus-Host Disease: MaaT Pharma’s groundbreaking Phase 3 results

The live biotherapeutics market is forecasted to exceed $4 billion by 2030, driven by advancements like MaaT013.

Gut to lung: how a new Akkermansia muciniphila strain is reshaping respiratory health

Its emergence in the respiratory health sector represents a paradigm shift, offering promising avenues for innovation and investment.

Optimizing iron supplementation with prebiotics: addressing deficiency and gut health

Raphaëlle Bourdet-Sicard from Danone Nutricia Research discusses a study which investigates the use of a mixed prebiotic formulation to enhance iron  absorption while mitigating adverse effects on gut microbiota. 

The role of gut microbiota imbalance in gut-liver axis dysfunction and cancer progression

Professor Maria Rescigno explores the critical role of the gut microbiota in maintaining intestinal barrier integrity and its implications for health. 

Metabolomics in alcohol dependence: uncovering biomarkers and gut-brain interactions through new technologies

Nathalie Maria Delzenne from Université Catholique de Louvain (Belgium) explains how gut microbiota and systemic inflammation impact cravings and depressive symptoms in affected individuals. 

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top